A Rave on a Pharma Practice
Copy paste from one PO'd Derek Lowe (again - both the cut and paste and the PO'd part).
And another criticism on Merck, who hasn't lacked for this sort of thing the past few years (Vioxx, Vytorin test results, etc.)
It centers around peer reviewed literature reporting and the source of those articles.
Guest Authorship and Ghostwriting in Publications Related to Rofecoxib
"If we’re going to win back the trust of the general public – which we’ve lost, in case anyone hasn’t noticed – we’re going to have to cut out the shortcuts, stop the doubletalk, and act as if what we’re doing (drug discovery) is something to be proud of."
I'm in this business as well, and also 'proud' of what I do. It isn't always glamorous (OK, ever glamorous), but the intent is noble. Sure is hard to find outside appreciation of late.